echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > Rubber Plastic News > Mitsubishi Chemical to acquire TPU business of AdvanSource Biomaterials

    Mitsubishi Chemical to acquire TPU business of AdvanSource Biomaterials

    • Last Update: 2022-08-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Mitsubishi Chemical Corporation announced that through Mitsubishi Chemical Performance Polymers, it will acquire the thermoplastic polyurethane elastomer (TPU) business of AdvanSourc Biomaterials in the United States


    .


    AdvanSourc Biomaterials has a high-quality TPU business in the United States, and its products are mainly used in medical devices such as cardiovascular catheters


    .


    Mitsubishi Chemical's performance polymers business has expanded globally through mergers and acquisitions and other measures, and currently offers various types of elastomer solutions


    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.